Article Details
Retrieved on: 2024-12-16 19:22:15
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Goldman Sachs nearing a deal to acquire Synthon, highlighting the strategic moves by financial firms like TPG and others involved. The key concept of 'healing' is implied in Synthon's role as a drugmaker. Tags reference the firms involved in the acquisition process.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here